Detalles de la búsqueda
1.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705160
2.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614146
3.
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
Ann Hematol
; 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459156
4.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
Blood
; 137(23): 3251-3258, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33513604
5.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Blood
; 138(24): 2499-2513, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34166502
6.
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis.
Ann Hematol
; 102(10): 2791-2801, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552322
7.
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Eur J Haematol
; 111(2): 220-228, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094812
8.
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.
Blood
; 135(3): 181-190, 2020 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697802
9.
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
Clin Endocrinol (Oxf)
; 96(6): 847-856, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743368
10.
Comparison of ABR and ASSR using narrow-band-chirp-stimuli in children with cochlear malformation and/or cochlear nerve hypoplasia suffering from severe/profound hearing loss.
Eur Arch Otorhinolaryngol
; 279(6): 2845-2855, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318333
11.
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
Int J Cancer
; 148(1): 150-160, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638373
12.
Investigations of the optical properties of enamel and dentin for early caries detection.
Clin Oral Investig
; 25(3): 1281-1289, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32613436
13.
Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.
Blood
; 131(4): 417-420, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196411
14.
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
Blood
; 131(2): 226-235, 2018 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29122756
15.
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
Br J Haematol
; 184(4): 616-624, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30095158
16.
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
Blood
; 129(3): 333-346, 2017 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864294
17.
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
Biol Blood Marrow Transplant
; 24(6): 1172-1179, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29605716
18.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27313086
19.
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
Blood
; 126(5): 604-11, 2015 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26022239
20.
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
Haematologica
; 102(8): 1413-1423, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411252